Skadden: Another Federal Court Adopts "Scope of Patent" Test for Analyzing Hatch-Waxman Patent Settlements: But Cases Against Cephalon Kept Alive | Practical Law

Skadden: Another Federal Court Adopts "Scope of Patent" Test for Analyzing Hatch-Waxman Patent Settlements: But Cases Against Cephalon Kept Alive | Practical Law

This Skadden, Arps, Slate, Meagher & Flom LLP memorandum discusses a case upholding lawsuits filed by the Federal Trade Commission (FTC) and private plaintiffs against drug maker Cephalon, Inc., alleging that Cephalon conspired with four generic drug manufacturers to delay generic competition for the wakefulness drug Provigil.

Skadden: Another Federal Court Adopts "Scope of Patent" Test for Analyzing Hatch-Waxman Patent Settlements: But Cases Against Cephalon Kept Alive

by Skadden, Arps, Slate, Meagher & Flom LLP
Published on 31 Mar 2010 • USA (National/Federal)
This Skadden, Arps, Slate, Meagher & Flom LLP memorandum discusses a case upholding lawsuits filed by the Federal Trade Commission (FTC) and private plaintiffs against drug maker Cephalon, Inc., alleging that Cephalon conspired with four generic drug manufacturers to delay generic competition for the wakefulness drug Provigil.